VxP Biologics provides extensive mammalian, microbial, and antiviral pharmaceutical R&D service offerings to support the preclinical and clinical development of your biologics and biosimilars.
- Cell line development
- Microbial strain development
- Vaccine Design & Development
- Customized protein expression systems
- Cell bank production
- Process development/Optimization
- Technology transfer
- Model development & Process characterization
Each customer project is customized to match the required scope and clinical phase. Commercial and in-house mammalian, microbial, and antiviral platform processes enable efficient movement through development programs and into commercialization.
Our Analytical Department is completely integrated with our R&D services to provide a consistent evaluation of your product throughout the entire development path. Our development team is also experienced with quick and efficient technology transfer to establish a variety of proven cell culture and microbial fermentation processes. We will ensure that you receive a seamless route from R&D to clinical scale-up and cGMP manufacturing.